Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,627,522 papers from all fields of science
Search
Sign In
Create Free Account
SUMO1 wt Allele
Known as:
SMT3H3
, PIC1
, GMP1
Expand
Human SUMO1 wild-type allele is located in the vicinity of 2q33 and is approximately 32 kb in length. This allele, which encodes small ubiquitin…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
2q33
DNA Repair
Interferon Signaling Process
Post-Translational Protein Processing
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Peptide Inhibitor of Complement C1 (PIC1) Inhibits Growth of Pathogenic Bacteria
P. Hair
,
M. Gregory Rivera
,
+6 authors
K. Cunnion
International Journal of Peptide Research and…
2019
Corpus ID: 25898534
Peptide Inhibitor of Complement C1 (PIC1) is a family of 15 amino acid peptides that inhibit complement activation via the…
Expand
2017
2017
Reversible regulation of ORC2 SUMOylation by PIAS4 and SENP2
Ronghua Wang
,
Fangming Liu
,
+4 authors
Chao Huang
OncoTarget
2017
Corpus ID: 5369112
The small ubiquitin-related modifier (SUMO) system is essential for smooth progression of cell cycle at the G2/M phase. Many…
Expand
2016
2016
Immortalization of epithelial cells in oral carcinogenesis as revealed by genome‐wide array comparative genomic hybridization: A meta‐analysis
V. K. Vincent-Chong
,
I. Salahshourifar
,
R. Razali
,
A. Anwar
,
R. Zain
Head and Neck
2016
Corpus ID: 3574837
This purpose of this meta‐analysis study was to identify the most frequent and potentially significant copy number alteration…
Expand
2014
2014
The E3 ligase APC/C-Cdh1 regulates MEF2A-dependent transcription by targeting SUMO-specific protease 2 for ubiquitination and degradation
Han Lu
,
B. Liu
,
+6 authors
Bu-wei Yu
Cell Cycle
2014
Corpus ID: 21337095
Activity-dependent stimuli induced a calcineurin-mediated dephosphorylation of the transcriptional factor MEF2A at serine408 and…
Expand
Review
2014
Review
2014
The interaction between DAP1 and autophagy in the context of human carcinogenesis.
U. Wazir
,
Zubair S. Khanzada
,
W. Jiang
,
A. Sharma
,
A. Kasem
,
K. Mokbel
Anticancer Research
2014
Corpus ID: 46449820
Autophagy is an evolutionarily-conserved catabolic process which furthers cell survival, especially in times of nutritional…
Expand
2014
2014
Correction: Genomic Restructuring in the Tasmanian Devil Facial Tumour: Chromosome Painting and Gene Mapping Provide Clues to Evolution of a Transmissible Tumour
The
PLoS Genetics
2014
Corpus ID: 1616161
An error was made in record keeping at the very start of this study regarding the strain classification of four of the tumour…
Expand
2012
2012
SENP2 regulates MEF2A de-SUMOylation in an activity dependent manner
Han Lu
,
B. Liu
,
+7 authors
Buwei Yu
Molecular Biology Reports
2012
Corpus ID: 18332984
SUMOylation has been shown to exert non-negligible influence on transcriptional factors and regulate genes expression by attuning…
Expand
2011
2011
Expanding NFκB and SUMO ties
Moon-hee Lee
,
S. Miyamoto
Cell Cycle
2011
Corpus ID: 46089215
Comment on: Lee MH, et al. Mol Cell 2011; 43:180-91.
2010
2010
SENP1 participates in the dynamic regulation of Elk-1 SUMOylation
James Witty
,
Elisa Aguilar-Martinez
,
A. Sharrocks
Biochemical Journal
2010
Corpus ID: 9241756
The modification of proteins with SUMO (small ubiquitin-related modifier) plays an important role in determining their functional…
Expand
1995
1995
Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression.
S. Denardo
,
P. Gumerlock
,
+7 authors
G. Denardo
Cancer Research
1995
Corpus ID: 18531163
Radioimmunotherapy (RIT) in breast cancer patients using I-131-chimeric L6 (ChL6) and in human breast cancer xenografts in nude…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE